alkenes has been researched along with tamoxifen in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, H; Schneider, MR; Schönenberger, H | 1 |
| Bodell, WJ; Burlingame, AL; Nakamura, T; Pathak, DN; Pongracz, K | 1 |
| Lee, HK; Li, SF; Ng, CL; Ong, CP | 1 |
| Bodell, WJ; Pathak, DN; Pongracz, K | 1 |
| Barakat, RR | 1 |
| Adams, MR; Schwenke, DC; Wagner, JD | 1 |
| Fallis, AG; Penwell, AJ; Souza, FE; Tessier, PE | 1 |
| Gust, R; Lubczyk, V | 2 |
| Itami, K; Kamei, T; Yoshida, J | 1 |
| McKinley, NF; O'Shea, DF | 1 |
| Inoue, E; Miyasaka, M; Nishihara, Y; Okamoto, M; Takagi, K; Takahashi, H; Tanemura, K | 1 |
| Gaudreault, RC; Lacroix, J; Landelle, G; Malo-Forest, B; Paquin, JF; Roy, JA | 1 |
| Abdellatif, KR; Belal, A; Omar, HA | 1 |
| Ganapathy, D; Sekar, G | 1 |
| Arbi, ME; Gargouri, A; Gupta, GK; Jaouen, G; Ketata, E; Mihoubi, W; Neifar, A; Pigeon, P; Top, S | 1 |
| Wang, Q; Wu, P; Yang, X; Yu, Z | 1 |
| Brauch, H; Eichelbaum, M; Johänning, J; Kröner, P; Mürdter, TE; Nörenberg, A; Schroth, W; Schwab, M; Thomas, M; Zanger, UM | 1 |
1 review(s) available for alkenes and tamoxifen
| Article | Year |
|---|---|
Tamoxifen and the endometrium.
Topics: Alkenes; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Endometrial Neoplasms; Endometrium; Estrogen Antagonists; Estrogens; Female; Genes, ras; Humans; Hyperplasia; Leiomyosarcoma; Mass Screening; Menopause; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Phenols; Polyps; Receptors, Estrogen; Risk; Tamoxifen | 1998 |
17 other study(ies) available for alkenes and tamoxifen
| Article | Year |
|---|---|
Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties.
Topics: Alkenes; Animals; Breast Neoplasms; Cell Line; Chemical Phenomena; Chemistry; Estrogen Antagonists; Female; Humans; Isomerism; Mammary Neoplasms, Experimental; Mice; Organ Size; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen; Terphenyl Compounds; Uterus | 1985 |
Activation of the tamoxifen derivative metabolite E to form DNA adducts: comparison with the adducts formed by microsomal activation of tamoxifen.
Topics: Alkenes; Animals; Benzene Derivatives; Biotransformation; DNA; DNA Adducts; Female; Horseradish Peroxidase; Microsomes, Liver; NADP; Oxidation-Reduction; Phenols; Rats; Tamoxifen | 1995 |
Determination of pharmaceuticals and related impurities by capillary electrophoresis.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Alkenes; beta-Cyclodextrins; Capillary Action; Chromatography, High Pressure Liquid; Cyclodextrins; Drug Contamination; Electrophoresis; gamma-Cyclodextrins; Hydrogen-Ion Concentration; Micelles; Ondansetron; Phenols; Reproducibility of Results; Sensitivity and Specificity; Tamoxifen; Technology, Pharmaceutical | 1994 |
Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen.
Topics: Alkenes; Animals; Biotransformation; DNA Adducts; Female; Horseradish Peroxidase; Liver; Molecular Structure; Peroxidases; Phenols; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1996 |
In vitro lipid peroxidation of LDL from postmenopausal cynomolgus macaques treated with female hormones.
Topics: Alkenes; alpha-Tocopherol; Amidines; Animals; Cholesterol, HDL; Copper; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; gamma-Tocopherol; Lipid Peroxidation; Lipoproteins, LDL; Macaca fascicularis; Medroxyprogesterone Acetate; Molecular Weight; Multivariate Analysis; Tamoxifen | 1999 |
(Z)-tamoxifen and tetrasubstituted alkenes and dienes via a regio- and stereospecific three-component magnesium carbometalation palladium(0) cross-coupling strategy.
Topics: Alkenes; Anticarcinogenic Agents; Magnesium; Organometallic Compounds; Palladium; Stereoisomerism; Tamoxifen | 2003 |
Investigations on the influence of terminal groups at the C2-propyl side chain of 1,1-bis(4-hydroxyphenyl)-2-phenylpent-1-ene and 1,1,2-tris(4-hydroxyphenyl)pent-1-ene on the estrogen receptor binding and the estrogenic/anti-estrogenic properties.
Topics: Alkenes; Binding, Competitive; Breast Neoplasms; Estradiol; Estrogen Receptor Modulators; Female; Humans; Inhibitory Concentration 50; Ligands; Luciferases; Plasmids; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen; Transfection; Tumor Cells, Cultured | 2003 |
Structure activity relationship studies on C2 side chain substituted 1,1-bis(4-methoxyphenyl)-2-phenylalkenes and 1,1,2-tris(4-methoxyphenyl)alkenes.
Topics: Alkenes; Animals; Antineoplastic Agents; Breast Neoplasms; Cattle; Cell Division; Cell Line, Tumor; Cytosol; Estradiol; Female; Humans; Hydroxylation; Luciferases; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen; Transcription, Genetic; Transfection; Uterus | 2003 |
Diversity-oriented synthesis of tamoxifen-type tetrasubstituted olefins.
Topics: Alkenes; Silanes; Tamoxifen | 2003 |
Carbolithiation of diphenylacetylene as a stereoselective route to (Z)-tamoxifen and related tetrasubstituted olefins.
Topics: Acetylene; Alkenes; Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Stereoisomerism; Tamoxifen | 2006 |
Zirconocene-mediated highly regio- and stereoselective synthesis of multisubstituted olefins starting from 1-alkynylboronates.
Topics: Alkenes; Boron; Chemistry, Organic; Chemistry, Pharmaceutical; Models, Chemical; Molecular Conformation; Organometallic Compounds; Stereoisomerism; Tamoxifen; Zirconium | 2007 |
Synthesis and growth inhibition activity of fluorinated derivatives of tamoxifen.
Topics: Alkenes; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Halogenation; HT29 Cells; Humans; MCF-7 Cells; Stereoisomerism; Tamoxifen | 2013 |
Design, synthesis and biological evaluation of novel triaryl (Z)-olefins as tamoxifen analogues.
Topics: Alkenes; Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Models, Molecular; Tamoxifen | 2013 |
Efficient synthesis of polysubstituted olefins using stable palladium nanocatalyst: applications in synthesis of tamoxifen and isocombretastatin A4.
Topics: Alkenes; Antineoplastic Agents; Catalysis; Hydrazones; Hydrocarbons, Iodinated; Molecular Structure; Palladium; Stilbenes; Tamoxifen | 2014 |
Aryl Butenes Active against K562 Cells and Lacking Tyrosinase Inhibitory Activity as New Leads in the Treatment of Leukemia.
Topics: Alkenes; Apoptosis; Binding Sites; Catalytic Domain; Cell Proliferation; Enzyme Inhibitors; Humans; Hydrogen Bonding; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Conformation; Molecular Docking Simulation; Monophenol Monooxygenase; Tamoxifen | 2018 |
Photoredox-Catalyzed C-H Arylation of Internal Alkenes to Tetrasubstituted Alkenes: Synthesis of Tamoxifen.
Topics: Alkenes; Carbon; Catalysis; Electrons; Molecular Structure; Oxidation-Reduction; Photochemical Processes; Tamoxifen | 2017 |
The formation of estrogen-like tamoxifen metabolites and their influence on enzyme activity and gene expression of ADME genes.
Topics: Alkenes; Cell Line; Cytochrome P-450 Enzyme System; Estrogens; Gene Expression Regulation, Enzymologic; Glucuronides; Glucuronosyltransferase; Hepatocytes; Humans; Microsomes, Liver; Phenols; Tamoxifen | 2018 |